Science now has the ability to individualize and customize a patient’s care, and also to assess the etiology of the problem—not solely treat the symptoms. Currently we can measure hormone levels, amino acids, vitamins, minerals, cardiovascular, genetic and oncologic biomarkers.
New studies and medical therapies to aid in the evaluation of the patient’s gastrointestinal tract have been developed. Each medication that is prescribed by a healthcare provider potentially causes a nutritional depletion that has not been previously assessed in the field of medicine.
We now have the capability to measure more than 35 nutrients at a cellular level in the body, and supplement the patient with the nutrients that are individualized to their specific needs based on environment and their own genetic histories. Our comprehensive assessment will provide personalized recommendations and integrative solutions to maximize you body’s vitality, immune function with an emphasis on health promotion and disease prevention.
We provide our clients with a variety of options when it comes to managing their overall well-being. Make the positive lifestyle change you have been wanting; see what Dr. Michelle Weiner has to offer you.
Physical therapy is an integral part of an effective injury-prevention and rehabilitation program. Physical therapists can evaluate your physical function and determine areas in which you must improve strength, flexibility, or endurance to reduce your chances of reinjury.
Regenerative medicine has been a recent clinical advancement in addressing the unmet need in sports medicine and orthopedics and well as anti-aging. There have been significant science advancements in technology and delivery strategy including autologous blood-derived therapies and PRP (Platelet Rich Plasma) injections to facilitate healing in joints, muscles, tendons, etc.
Supplementing with nutritional solutions can be a great option for pain that is not specifically caused by a degenerative or major acute medical condition. The supplements provide an effective treatment plan that are tailored to each patient.
© 2023 Dr. Michelle Weiner, DO, MPH
Literature suggests that the use of virtual reality distraction for adjunctive pain control has been successful. In clinical settings and experimental studies, participants immersed in a virtual reality experienced reduced levels of pain, general distress/unpleasantness and reported a desire to use virtual reality again during painful medical procedures.
There has been research into the use of virtual reality distraction for adjunctive pain control with significant success. There has been growing evidence for the use of EEG for the measurement of pain. It has also been suggested that virtual reality could be used an alternative to marijuana and opioids for pain management. Further implications have been seen specifically among chronic pain sufferers. This is especially interesting since there is a reduced risk of addiction as is seen associated with marijuana and opioid use. This study aims to investigate the effect of virtual reality distraction on pain perception.
Additionally, we intend to create a body of open source content for potential use by other investigators utilizing similar tools.
The intervention has the potential to relieve chronic pain sufferers of their pain with a non-invasive mechanism and minimal risk. The participants may experience a temporary decrease in the perception of pain during the course of the experiment or a distraction from said pain.
Pending IRB approval at UM
The purpose of this study is to identify what is effective and safe for older adults with chronic pain to develop an understanding of what educational materials are required for facilitate access to appropriate products at medical marijuana treatment centers (MMTC).
Survey older adults (> 50 years) with chronic pain who have MM access cards and receive their product from state-approved dispensaries to document: demographic/health data; patterns of use; product specifics; pain effects on daily life; pain-related medical conditions; education prior to MM purchase; helpful and problematic effects of MM use.
The proportion of Florida’s population that is 60 and older is growing more rapidly than other components of the population. Musculoskeletal disorders with associated chronic pain are a common problem in later life. Symptom management in older adults, including chronic pain management can be challenging (Briscoe, 2018). Medications, especially opioids, can increase the risk of confusion, constipation, falls and injury (Briscoe,2018). Medical marijuana (MM) is often recommended by doctors in the treatment of these medical conditions, guided by state law that defines qualifying conditions.
Medical marijuana use among older adults is growing at a rate more rapid than younger age groups (Lum, et al, 2019). The 2016 National Survey on Drug Use and Health estimated a 2.9% prevalence of marijuana use among this older population. However, the survey did not ascertain if use was for medical or recreational purposes (Han et al., 2016). Older adults may have important differences in pathophysiology, pharmacological interaction of medications, comorbid conditions, and toxicological responses to cannabis.
There is little evidence to evaluate the differences associated with medical marijuana use among older adults, such as individual reasons for use and problems arising with use (Haug et al., 2017).
Chronic pain is a major public health problem. Approximately 178 million (41%) adults in the U.S. age 18 and older suffer from at least one painful health condition (Nahin, et al, 2019).
In Florida, there are 327,492 medical marijuana card holders and chronic non-malignant pain was the No. 1 diagnosis for which patients are registered (The Florida Department of Health, Office of Medical Marijuana Use, 2020). Yet, it is not a qualifying condition, creating challenges for physicians wishing to support patient use of MM for chronic pain.
Chronic pain accounted for nearly 34 percent of diagnoses at certified dispensaries (The Florida Department of Health, Office of Medical Marijuana Use, 2019).
